ArticlePharmaceutics2021

Tyrosine Kinase Inhibitors Are Promising Therapeutic Tools for Cats with HER2-Positive Mammary Carcinoma.

Andreia Gameiro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.